Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution relieves intraocular pressure to treat glaucoma. Dorzolamide HCL/Timolol Maleate Ophthalmic Solution decreases the amount of fluid in the eye. Lowering eye pressure helps to prevent blindness.
Possible Side Effects
The most frequently reported adverse reactions associated with Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solution were ocular burning, stinging, or discomfort immediately following ocular administration (approximately one-third of patients).
Approximately one-quarter of patients noted a bitter taste following administration. Superficial punctate keratitis occurred in 10 to 15% of patients and signs and symptoms of ocular allergic reaction in approximately 10%.
Drug & Food Interactions
There is a potential for an additive effect on the known systemic effects of carbonic anhydrase inhibition in patients receiving an oral carbonic anhydrase inhibitor and Dorzolamide HCl Ophthalmic Solution. The concomitant administration of Dorzolamide HCl Ophthalmic Solution and oral carbonic anhydrase inhibitors is not recommended.
Dorzolamide HCl Ophthalmic Solution contains dorzolamide, a sulfonamide; and although administered topically, it is absorbed systemically. Therefore, the same types of adverse reactions that are attributable to sulfonamides may occur with topical administration of Dorzolamide HCl Ophthalmic Solution.
This drug is FDA-approved for human use. However, it is common practice for veterinarians to prescribe such drugs for use in dogs and cats.
Store at 68°F – 77°F. Protect from light.
NOTE: For Generic Medications, picture displayed may not depict actual product. Generic medications may vary from one order to the next by size, color and shape depending on manufacturer.